Trademark: 97898612
Word
QUIVER BIOSCIENCE
Status Date
Monday, May 6, 2024
Filing Date
Thursday, April 20, 2023
Abandoned Date
Monday, April 22, 2024
42 Development of new technology for others in the field of understanding and addressing the molecular causes of neurological diseases and developing clinical therapies for neurological diseases with precision drug development platforms.; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields
Apr 24, 2023
New Application Entered
Apr 27, 2023
Teas Voluntary Amendment Received
May 16, 2023
New Application Office Supplied Data Entered
Sep 13, 2023
Assigned To Lie
Sep 13, 2023
Preliminary/Voluntary Amendment - Entered
Jan 18, 2024
Assigned To Examiner
Jan 19, 2024
Non-Final Action Written
Jan 19, 2024
Non-Final Action E-Mailed
Jan 19, 2024
Notification Of Non-Final Action E-Mailed
May 6, 2024
Abandonment - Failure To Respond Or Late Response
May 6, 2024
Abandonment Notice E-Mailed - Failure To Respond
Trademark Alertz updated from USPTO on 2030-01-24